Queens College, The City University of New York

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Queens College, The City University of New York sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials 1 currently recruiting 3 completed early-phase tilt upper quartile by trial count

Queens College, The City University of New York: 8 sponsored US clinical trials, 1 recruiting.

Queens College, The City University of New York sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 1 trials.

Upper-quartile sponsor footprint

Queens College, The City University of New York sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Queens College, The City University of New York pipeline

1 recruiting of 8 indexed (13% open); 3 completed (38%).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Aging (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Queens College, The City University of New York: open-pipeline peers nationwide

Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

Queens College, The City University of New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 681012141618 0%10%20%30%40% Total trials Recruiting share Queens College, The City University of New YorkAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Addario Lung Cancer Medical InstituteAmerican UniversityAnnexonAnsun Biopharma
Queens College, The City University of New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Queens College, The City University of New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this Queens College, The City University of New York page

8 registered trials is a research-attention snapshot, not an endorsement of Queens College, The City University of New York or any single study.

  • 1 of Queens College, The City University of New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Aging is the condition Queens College, The City University of New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Queens College, The City University of New York pipeline card: 8 registered trials from official public datasets.Report a data error.